首页> 外文会议> >Photodynamic treatment of the RIF-1 tumor with verteporfin with online monitoring of tissue oxygen using electron paramagnetic resonance oximetry
【24h】

Photodynamic treatment of the RIF-1 tumor with verteporfin with online monitoring of tissue oxygen using electron paramagnetic resonance oximetry

机译:韦替泊芬对RIF-1肿瘤的光动力治疗,通过电子顺磁共振血氧测定法在线监测组织氧

获取原文
获取原文并翻译 | 示例

摘要

Abstract: In this study, treatment of the RIF-1 tumor was examined with photodynamic therapy using Verteprofin (formerly benzoporphyrin derivative, BPD). The effects of two different optical dose rates were examined, with no detectable difference in the tumor regrowth time. Oxygen consumption during PDT could reliably be monitored with electron paramagnetic resonance (EPR) oximetry using an implanted paramagnetic material within the tumor. A reduction of the tumor pO$-2$/ was detected in the animals that were followed after treatment, suggesting that there was a compromise to the tumor vasculature that persisted throughout the measurements. At high total doses some of the tumors did not regrow. Altogether these results are indicative of the tumor destruction being caused by destruction of the blood vessels from the treatment. !29
机译:摘要:在这项研究中,使用Verteprofin(原苯并卟啉衍生物,BPD)通过光动力疗法检查了RIF-1肿瘤的治疗。检查了两种不同的光学剂量率的影响,在肿瘤再生时间上没有可检测的差异。使用植入肿瘤内的顺磁材料,可以通过电子顺磁共振(EPR)血氧测定法可靠地监测PDT期间的耗氧量。在治疗后追踪的动物中检测到肿瘤pO 2-2的降低,这表明在整个测量过程中持续存在的肿瘤脉管系统存在折衷。在高总剂量下,一些肿瘤没有再生长。总而言之,这些结果表明肿瘤的破坏是由治疗中血管的破坏引起的。 !29

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号